James Levine - 12 Jul 2021 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Financial Officer
Signature
/s/ James Levine
Issuer symbol
CRDF
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
12 Jul 2021, 16:16:15 UTC
Next filing
13 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Common Stock Award $0 +390,000 $0.000000 390,000 12 Jul 2021 Stock Options 390,000 $6.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 97,500 vest on 7/12/2022. 8,125 vest monthly for 36 months beginning on 8/12/2022 through 7/12/2025.